FAM
TBIO

Fred Alger Management’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Fred Alger Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,503
Closed -$275K – 571
2022
Q2 		$275K Sell
8,503
-174
-2% -$12K ﹤0.01% 418
2022
Q1 		$839K Sell
8,677
-47
-0.5% -$7.13K ﹤0.01% 401
2021
Q4 		$1.7M Sell
8,724
-307
-3% -$47.8K ﹤0.01% 368
2021
Q3 		$1.81M Buy
9,031
+177
+2% +$44.9K ﹤0.01% 352
2021
Q2 		$3.51M Buy
+8,854
New +$3.13M 0.01% 323

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fred Alger Management's TBIO Position: Q3 2022 in Review

Fred Alger Management sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2022, closing a stake of 8,503 shares — an estimated $275K sold.

Fred Alger Management first reported a position in TBIO in Q2 2021 and held it in 5 quarters. The position peaked at $3.51M in Q2 2021. 32 funds tracked by Wall St. Rank hold TBIO as of Q3 2022.

  • Fred Alger Management reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Fred Alger Management sold 8,503 Telesis Bio, Inc. Common Stock shares in Q3 2022, an estimated $275K.
  • Fred Alger Management first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • Fred Alger Management's Telesis Bio, Inc. Common Stock position peaked at $3.51M in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2022.

Based on Fred Alger Management's 13F filing for Q3 2022, filed 15 Nov 2022.